Ian C Schoenhofen

Title: Innovations of Ian C Schoenhofen

Introduction

Ian C Schoenhofen is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of therapeutic innovations, particularly in combating antibiotic resistance. With a total of 8 patents to his name, his work is at the forefront of addressing critical health challenges.

Latest Patents

One of his latest patents focuses on a therapeutic based on CMP-nonulosonate sugars, which has shown resistance to nearly all conventional antibiotics. This invention describes the use of CMP-nonulosonate analogues to counter gonococcal complement evasion. The incorporation of the nonulosonate sugar into the lipooligosaccharide reduces the serum resistance of the bacteria, providing a novel therapeutic strategy against the global threat of multi-drug resistant gonorrhea. Another significant patent involves the cell-based production of bacterial nonulosonates and their biosynthetic precursors. This invention provides recombinant cells for the production of pseudaminic acid, legionaminic acid, and other important compounds, along with methods for producing these sugars.

Career Highlights

Ian has worked with esteemed organizations such as the National Research Council of Canada and the University of Ottawa. His career reflects a commitment to advancing scientific knowledge and developing innovative solutions to pressing health issues.

Collaborations

Ian has collaborated with notable colleagues, including Dennis M Whitfield and Susan M Logan. These partnerships have contributed to the success of his research and innovations.

Conclusion

Ian C Schoenhofen's work exemplifies the impact of innovation in the field of therapeutics. His patents and collaborations highlight his dedication to addressing critical health challenges, particularly in the fight against antibiotic resistance.